| scholarly article | Q13442814 |
| P356 | DOI | 10.18632/ONCOTARGET.15348 |
| P8608 | Fatcat ID | release_5xqlwvewl5hirlfoqdhylqs3rm |
| P932 | PMC publication ID | 5400552 |
| P698 | PubMed publication ID | 28209916 |
| P50 | author | Vicente A Torres | Q64764422 |
| Rafaela Erices | Q84329119 | ||
| Renan Orellana | Q85322532 | ||
| Gareth I Owen | Q92421599 | ||
| Galdo Bustos | Q95949488 | ||
| Sofía Cubillos | Q115314190 | ||
| P2093 | author name string | Sumie Kato | |
| Monica Marquez | |||
| Jaime Pereira | |||
| Alejandro S Godoy | |||
| Bárbara Oliva | |||
| Carolina Ibañez | |||
| Carolina Ramírez | |||
| Catalina Alonso | |||
| Clemente Arab | |||
| Erasmo Bravo | |||
| Felice Santoro | |||
| Jorge Brañes | |||
| Julio Cesar Cardenas | |||
| Karen García | |||
| María Loreto Bravo | |||
| Mauricio A Cuello | |||
| Pamela González | |||
| Patricia Fuenzalida | |||
| Raúl Aravena | |||
| P2860 | cites work | Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 |
| Platelet effects on ovarian cancer | Q26829401 | ||
| Metformin in cancer: translational challenges | Q26866388 | ||
| Cellular and molecular mechanisms of metformin: an overview | Q27013561 | ||
| FAK in cancer: mechanistic findings and clinical applications | Q27026533 | ||
| Metformin and reduced risk of cancer in diabetic patients | Q29616275 | ||
| Platelet granule secretion continuously prevents intratumor hemorrhage | Q30483704 | ||
| Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells | Q30576959 | ||
| The physiology of platelet production | Q33334397 | ||
| Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage | Q33369958 | ||
| Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency Situations | Q33845157 | ||
| Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK). | Q33946957 | ||
| Platelets guide the formation of early metastatic niches | Q34002250 | ||
| Radiosensitization of pancreatic cancer cells by metformin through the AMPK pathway | Q34040261 | ||
| Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review | Q34109435 | ||
| In vivo evidence for platelet-induced physiological angiogenesis by a COX driven mechanism | Q34215849 | ||
| Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors | Q34442318 | ||
| Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. | Q34887704 | ||
| Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current | Q34957274 | ||
| Evidence that platelets promote tube formation by endothelial cells on matrigel. | Q35028157 | ||
| Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway | Q35029506 | ||
| Compound C Inhibits Vascular Smooth Muscle Cell Proliferation and Migration in an AMP-Activated Protein Kinase-Independent Fashion | Q35122850 | ||
| Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis | Q35153802 | ||
| Beneficial effects of metformin on haemostasis and vascular function in man. | Q35539943 | ||
| Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. | Q35540959 | ||
| Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity. | Q35629996 | ||
| Targeting AMPK for cancer prevention and treatment | Q35781311 | ||
| Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells | Q35884622 | ||
| Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells | Q36419610 | ||
| Platelets increase the proliferation of ovarian cancer cells | Q36462411 | ||
| Metformin intake is associated with better survival in ovarian cancer: a case-control study | Q36557010 | ||
| Anti-angiogenic Effects of Metformin, an AMPK Activator, on Human Umbilical Vein Endothelial Cells and on Granulation Tissue in Rat | Q36821921 | ||
| FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal | Q36867341 | ||
| Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. | Q37205539 | ||
| Metformin, at Concentrations Corresponding to the Treatment of Diabetes, Potentiates the Cytotoxic Effects of Carboplatin in Cultures of Ovarian Cancer Cells | Q37280136 | ||
| Metformin therapy associated with survival benefit in lung cancer patients with diabetes | Q37376577 | ||
| Metformin: taking away the candy for cancer? | Q37775372 | ||
| The platelet contribution to cancer progression | Q37805788 | ||
| The role of blood platelets in tumor angiogenesis | Q37822079 | ||
| Mechanisms of platelet activation by thrombin: A short history | Q37964279 | ||
| Metformin, cancer and glucose metabolism | Q38255936 | ||
| Effects of oral hypoglycemic agents on platelet function | Q38508849 | ||
| Platelets in cancer metastasis: To help the "villain" to do evil | Q38584175 | ||
| Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro | Q38854319 | ||
| Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status | Q38942314 | ||
| p53 modulates the AMPK inhibitor compound C induced apoptosis in human skin cancer cells | Q39219080 | ||
| Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway. | Q39639032 | ||
| Enhanced chemoresistance and tumor sphere formation as a laboratory model for peritoneal micrometastasis in epithelial ovarian cancer. | Q39701137 | ||
| A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line | Q39774191 | ||
| Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions | Q41963534 | ||
| Metformin inhibits inflammatory angiogenesis in a murine sponge model | Q43201275 | ||
| The effect of metformin on mean platelet volume in dıabetıc patients | Q43982348 | ||
| The direct effects of metformin on platelet function in vitro | Q46584886 | ||
| Dorsomorphin stimulates neurite outgrowth in PC12 cells via activation of a protein kinase A-dependent MEK-ERK1/2 signaling pathway. | Q51851159 | ||
| Metformin action: concentrations matter | Q52970022 | ||
| Prostaglandins and platelet aggregation. | Q54541982 | ||
| Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop. | Q54599219 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metformin | Q19484 |
| ovarian cancer | Q172341 | ||
| P304 | page(s) | 20865-20880 | |
| P577 | publication date | 2017-02-15 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Diabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression | |
| P478 | volume | 8 |
| Q92421604 | Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation |
| Q57478732 | Diphlorethohydroxycarmalol Isolated from Represses High Glucose-Induced Angiogenesis In Vitro and In Vivo |
| Q92618041 | Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis |
| Q41080847 | Marketed drugs used for the management of hypercholesterolemia as anticancer armament |
| Q64105328 | Metformin induces the AP-1 transcription factor network in normal dermal fibroblasts |
| Q47265780 | The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis |
Search more.